Written by Admin | Apr 10, 2019
The FDA is partnering with Brigham and Women's Hospital and Aetion to expand its use of real-world evidence (RWE) in predicting clinical outcomes from trials. This collaboration aims to identify when and how RWE can provide reliable estimates of safety and efficacy to support sNDAs. By leveraging Aetion's platform and healthcare claims data, the partners will predict safety and efficacy outcomes for seven ongoing clinical trials.
Read More